Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2008, Vol. 111, No. 2, pp. 473-474.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mosher, D. F.
Right arrow Articles by Britt Carlson, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mosher, D. F.
Right arrow Articles by Britt Carlson, C.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

InsideBlood

INSIDE BLOOD

Comment on Isenberg et al, page 613

Secreted thrombospondin-1 controls platelet sensitivity to NO

Deane F. Mosher, Lisa M. Maurer, and C. Britt Carlson

UNIVERSITY OF WISCONSIN

Many functions have been suggested for the large amounts of thrombospondin-1 that are stored in {alpha}-granules of platelets. Isenberg et al describe a new role whereby thrombospondin-1 counteracts NO and allows platelet activation to take place in situations in which NO is being generated.

In this issue of Blood, Isenberg and colleagues describe a novel function for thrombospondin-1 (THBS-1) in the {alpha}-granules of platelets: THBS-1 opposes nitric oxide (NO) and allows platelet activation when NO is being generated. This insight may complete the solution of an intriguing puzzle. {alpha}-granules are loaded with THBS-1, but mice with knock-out of the THBS-1 gene have normal tail bleeding times and platelets that aggregate normally after washing and activation with thrombin.1 In contrast, mice with knock-out of THBS-2, which is closely related to THBS-1 but not present in {alpha}-granules, have grossly dysfunctional platelets.2,3 Part of the puzzle was solved several years ago when Kyriakides et al3 demonstrated that THBS-2 is present in the marrow microenvironment and needed by megakaryocytes for production of normal platelets. Until now, we have not known of a compelling role for THBS-1 in platelet function.

The figure depicts the ribbon structure of THBS-1 and THBS-2. The THBS subunit has an N-terminal module (N); an oligomerization sequence (o) that forms a trimeric {alpha}-helical coiled-coil; 1 von Willebrand factor-C (C), 3 properdin (P1, P2, P3), and 3 EGF-like (E1, E2, E3) modules; a THBS wire module with 13 calcium ion-binding repeats; and a C-terminal lectin-like module. Approximately 30 calcium ions (shown as red balls) bind per subunit.4 Sites where THBS-1 interacts with platelet proteins are indicated. Putative cell surface receptors include {alpha}6β1, {alpha}IIbβ3, and {alpha}Vβ3 integrins; CD36, which binds to the properdin modules; and CD47, which binds to the lectin-like module. In addition, THBS-1 binds to fibrinogen associated with the platelet surface, activates latent TGF-β secreted from platelets, and disassembles VWF multimers by a disulfide exchange requiring the free cysteine in the lectin-like module. Interactions important for counteracting the effects of NO on platelet aggregation were found to involve CD36 and CD47 and to be mimicked by the appropriate segment of THBS-1 or peptides based on sequences in properdin modules (for CD36) or the lectin-like module (for CD47).

Surprisingly, ligation of either CD36 or CD47 suffices to counteract NO. Prior studies showed that THBS-1 also counteracts stimulation of endothelial or vascular smooth muscle cells by NO.5 Study of smooth muscle cells from mice null in CD36 or CD47 indicates that CD47 is necessary to counteract NO when the cells are presented with reagents that ligate CD36 or CD47 but that CD36 is not necessary for a CD47 ligand to counteract NO.5 Although such experiments are not presented for platelets, the summary mechanistic figure depicts a pathway whereby ligation of CD36 causes a signal that is funneled through CD47.

Exogenous THBS-1 counteracted the effects of exogenous NO on thrombin-induced platelet aggregation and production of cGMP with the same dose responses. THBS-1 in the range of only 22 pM to 22 nM (3.3 ng/mL to 3.3 µg/mL) was required. Importantly, comparisons of platelets from wild-type and THBS-1–null mice demonstrated that endogenously released THBS-1 can counteract NO. Decreased production of cGMP in the presence of THBS-1 indicated that soluble guanylyl cyclase is a target of ligated CD47. Evidence is also presented for signaling from ligated CD47 to inhibit cGMP-dependent protein kinase and downstream phosphorylation of VASP and activation of Rap1.

The paper from Isenberg et al does raise questions. First, what are the molecular interactions and reactions that link ligated CD36 to CD47 and allow CD47 to modulate the activities of soluble guanylyl cyclase and cGMP-dependent protein kinase? Second, why are the platelet stores of THBS-1 so large, if so little is needed to counteract NO? The serum concentration of THBS-1 is 15 to 30 µg/mL, and its calculated concentration in {alpha}-granules is 60 mg/mL.6 Third, how are CD-47–binding sequences exposed in the lectin-like module? Peptides that ligate CD47 are based on sequences that are buried in the module.4 Loss of calcium ions is associated with major rearrangements of the convoluted structure of the EGF-like modules, wire, and lectin-like module7 and may expose the CD-47 binding sequences. It is a good bet that THBS-1 stored in {alpha}-granules lacks a full complement of bound calcium because so much calcium would be required. Finally, do THBSs other than THBS-1 modulate effects of NO? Only THBS-1 and THBS-2 have properdin modules to interact with CD36, but all 5 tetrapod THBSs have lectin-like modules for possible interaction with CD-47.


Figure 1
Conceptual ribbon diagram of THBS-1 or THBS-2. The structures used to make the model are of recombinant constructs from 5 different proteins. Sites of interaction of THBS-1 with platelet proteins are indicated by arrows.

THBS-1 has been assigned many roles in platelet and vascular biology. Will its major and lasting role be as a modulator of NO? If so, there are many pathophysiological ramifications, and we may expect some very interesting plot lines.

Footnotes

Conflict-of-interest disclosure: The authors declare no competing financial interests. {blacksquare}

REFERENCES

  1. Lawler J, Sunday M, Thibert V, et al. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 1998; 101:982–992.[Medline] [Order article via Infotrieve]

  2. Kyriakides TR, Zhu YH, Smith LT, et al. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 1998; 140:419–430.[Abstract/Free Full Text]

  3. Kyriakides TR, Rojnuckarin P, Reidy MA, et al. Megakaryocytes require thrombospondin-2 for normal platelet formation and function. Blood 2003; 101:3915–3923.[Abstract/Free Full Text]

  4. Carlson CB, Bernstein DA, Annis DS, et al. Structure of the calcium-rich signature domain of human thrombospondin-2. Nat Struct Mol Biol 2005; 12:910–914.[CrossRef][Medline] [Order article via Infotrieve]

  5. Isenberg JS, Ridnour LA, Dimitry J, Frazier WA, Wink DA, Roberts DD. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 2006; 281:26069–26080.[Abstract/Free Full Text]

  6. Mosher DF, Pesciotta DM, Loftus JC, Albrecht RM. Secreted alpha granule proteins: The race for receptors. In George JN, Nurden AT, Phillips DR (Eds.). Platelet Membrane Glycoproteins1985;New York Plenum Press pp. 171–191.

  7. Annis DS, Gunderson KA, Mosher DF. Immunochemical analysis of the structure of the signature domains of thrombospondin-1 and thrombospondin-2 in low calcium concentrations. J Biol Chem 2007; 282:27067–27075.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling
Jeff S. Isenberg, Martin J. Romeo, Christine Yu, Christine K. Yu, Khauh Nghiem, Jude Monsale, Margaret E. Rick, David A. Wink, William A. Frazier, and David D. Roberts
Blood 2008 111: 613-623. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mosher, D. F.
Right arrow Articles by Britt Carlson, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mosher, D. F.
Right arrow Articles by Britt Carlson, C.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020